Jamp Pharma Corporation
1 clinical trials · Sponsor
◉ Watch Jamp Pharma Corporation
| Record | Firm | Date |
|---|---|---|
| The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications. (NCT05913817) | Jamp Pharma Corporation | 2023-01-09 |
Track Jamp Pharma Corporation automatically
Every clearance here is in the API, with alerts when new ones post.